Oct 20, 2022
FDA
The new article provides additional details regarding some of the matters related to evidence, including the benefit-risk assessment. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare...
Read More
Oct 20, 2022
FDA
The article provides a brief overview of the approach to be applied for medical device recalls and enhancements, including the determination of their regulatory nature and the requirements to be followed. Table of Contents The Food and Drug Administration (FDA or the...
Read More
Oct 20, 2022
FDA
The new article describes in detail the regulatory requirements to be applied concerning pivotal clinical investigations in terms of clinical evidence for domestic and foreign clinical studies. Table of Contents The Food and Drug Administration (FDA or the Agency),...
Read More
Oct 14, 2022
FDA
The article provides an overview of the regulatory policy related to the Abbreviated 510(k) Program and highlights the key points associated thereto. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of...
Read More
Oct 14, 2022
FDA
The article provides an overview of the regulatory policy for pivotal clinical investigations in terms of design considerations. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products,...
Read More